Cargando…
Emerging Treatments for Reactive Cutaneous Capillary Endothelial Proliferation
BACKGROUND: Reactive cutaneous capillary endothelial proliferation (RCCEP) is a common, burdensome adverse event that occurs in up to 88% of patients treated with camrelizumab. Without treatment, RCCEP is associated with social stigma and low quality of life. However, the optimal management of RCCEP...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162724/ https://www.ncbi.nlm.nih.gov/pubmed/37151267 http://dx.doi.org/10.4103/ijd.ijd_505_22 |